scispace - formally typeset
E

Erik Bruyneel

Researcher at Ghent University

Publications -  69
Citations -  4725

Erik Bruyneel is an academic researcher from Ghent University. The author has contributed to research in topics: Cadherin & Catenin complex. The author has an hindex of 34, co-authored 69 publications receiving 4589 citations.

Papers
More filters
Journal ArticleDOI

The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion

TL;DR: It is reported that expression of wild-type but not of mutated SIP1 downregulates mammalian E-cadherin transcription via binding to both conserved E2 boxes of the minimal E- cadheringin promoter.
Journal ArticleDOI

The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program

TL;DR: It is reported that conditional expression of the human transcriptional repressor Snail in colorectal cancer cells induces an epithelial dedifferentiation program that coincides with a drastic change in cell morphology.
Journal ArticleDOI

Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho-, and Rac-dependent signaling pathways

TL;DR: It is indicated that leptin may exert a local and beneficial effect on migration of normal colonic epithelial cells and reparation of the inflamed or wounded digestive mucosa, linking the nutritional and body fat status to digestive cancer susceptibility by stimulating the invasive capacity of colonichelial cells at early stages of neoplasia.
Journal ArticleDOI

Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness.

TL;DR: It is proposed that the recruitment of PTEN at adherens junctions by MAGI‐1b and the local down‐regulation of phosphatidylinositol‐3,4,5‐trisphosphate pools and downstream effector systems at the site of cell‐cell contacts are focal points for restraining both disruption of junctional complexes and induction of tumor cell invasion.
Journal Article

The c-kit Tyrosine Kinase Inhibitor STI571 for Colorectal Cancer Therapy

TL;DR: Encouraging results warrant further preclinical investigations and clinical trials on the use of the c-kit inhibitor STI571 as a chemotherapeutic agent in colon cancer prevention and in treatment of advanced colorectal cancers associated with liver metastases.